SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
48 hedge funds and large institutions have $47.9M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
48
Holding in Top 10
1
Calls
$1.04M
Puts
–
Top Buyers
| 1 | +$3.1M | |
| 2 | +$1.99M | |
| 3 | +$438K | |
| 4 |
BlackRock
New York
|
+$130K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$116K |
Top Sellers
| 1 | -$86K | |
| 2 | -$61.7K | |
| 3 | -$40.4K | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$38.4K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$37.8K |